Combination immunotherapy with GM-CSF and CTLA-4 blockade for hormone refractory prostate cancer: Balancing the expansion of activated effector and regulatory T cells
Year: 2007
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: L. Fong, B. Kavanagh, Y. Hou, S. O’Brien, J. Valiente, V. Weinberg, B. I. Rini, E. J. Small
Institutions: Cleveland Clinic, University of California, San Francisco
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2596607828
